GridAI Appoints Marshall Chapin as New CEO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 04 2025
0mins
GridAI Technologies announced the appointment of Marshall Chapin as CEO of its energy-orchestration operating subsidiary developing next-generation grid and power-management software for hyperscale artificial-intelligence data-center campuses. Chapin, since March of 2025, has served as Chief Commercial Officer and Interim CEO of Amp X, a GridAI subsidiary and AI-driven grid-edge platform.
Analyst Views on GRDX
About GRDX
GridAI Technologies Corp., formerly Entero Therapeutics, Inc., offers a grid-edge, artificial intelligence (AI)-driven software and control platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources, including battery energy storage systems. It applies real-time AI scheduling and optimization to orchestrate devices, fleets, and grid-scale assets. The Company also focuses on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company's programs address significant unmet needs in GI health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
